{
    "nct_id": "NCT04207359",
    "official_title": "The THRIVE Study: An Open-Label Randomized Trial of Exercise ± Creatine Supplementation to Augment the Adaptations of Exercise Training in Breast Cancer Survivors",
    "inclusion_criteria": "* Age 18-75 years of age\n* Recent (within 6 months) completion of chemotherapy\n* Willing to attend 3 virtual exercise sessions per week\n* Able to take oral medications\n* Participant is willing and able to provide consent to participating in the study\n* Serum creatinine ≤ 1.5 x ULN or Estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2 by Chronic Kidney Disease Epidemiology Collaboration equation.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Physical indications where performing exercise may be limited and/or contraindicated\n* Poorly-controlled hypertension (blood pressure > 160/95mmHg)\n* Current tobacco use (within 6 months)\n* Anabolic steroids use\n* Pitting edema\n* Currently undergoing chemotherapy\n* History of moderate-severe heart disease (New York Heart Classification greater than grade II) or pulmonary disease (dyspnea on exertion upon climbing one flight of stairs or less; abnormal breath sounds on auscultation).\n* Pregnant or plan to get pregnant during the study\n* Recent (within one month) or anticipated treatment with corticosteroids (except for short term use during the time of chemotherapy), androgens, progestational agents, or other appetite stimulants\n* Serum creatinine > 1.5 x ULN or Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 by Chronic Kidney Disease Epidemiology Collaboration equation.\n* Currently taking creatine supplements",
    "miscellaneous_criteria": ""
}